Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Low‐density lipoprotein cholesterol and lifespan: A Mendelian randomization study

11 Mar 2021

Abstract excerpt

Aims It is unknown whether long‐term low‐density lipoprotein cholesterol (LDL‐c) lowering increases lifespan and longevity in a general population not selected for elevated cardiovascular risk. The present study aimed to investigate the overall and gene‐specific effect of circulating LDL‐c levels on lifespan and longevity in a general population. Methods Leveraging data from the Global Lipids Genetics Consortium...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Associations and Epidemiology
Share to Genetics, Aging, and Longevity in Model Organisms
Share to Lipoproteins and Cardiovascular Health

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33704808
DOI: 10.1111/bcp.14811

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Low‐density lipoprotein cholesterol and lifespan: A Mendelian randomization studyPMID 33704808Read ↗

Genetically-predicted life-long lowering of low-density lipoprotein cholesterol is associated with decreased frailty: A Mendelian randomization study in UK biobankSemantic proximity Read ↗

Genetically instrumented LDL-cholesterol lowering and multiple disease outcomes: A Mendelian randomization phenome-wide association study in the UK Biobank.Semantic proximity Read ↗

Causal effects of lipid-lowering therapies on aging-related outcomes and risk of cancers: a drug-target Mendelian randomization study.Semantic proximity Read ↗

Efficacy and safety of low levels of low-density lipoprotein cholesterol: trans-ancestry linear and non-linear Mendelian randomization analysesSemantic proximity Read ↗

Factorial Mendelian randomization of lipoprotein (a) lowering, low-density lipoprotein cholesterol lowering, and lifestyle improvements: joint associations with cardiovascular risk.Semantic proximity Read ↗

Modifiable pathways for longevity: A Mendelian randomization analysis.Semantic proximity Read ↗

Comprehensive Mendelian randomization analysis of low-density lipoprotein cholesterol and multiple cancersSemantic proximity Read ↗

Comprehensive Mendelian randomization analysis of low-density lipoprotein cholesterol and multiple cancersSemantic proximity Read ↗

Telomere length and the risk of cardiovascular diseases: A Mendelian randomization studySemantic proximity Read ↗

Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis.Semantic proximity Read ↗

LDL cholesterol still a problem in old age? A Mendelian randomization study.Semantic proximity Read ↗

Exploring repositioning opportunities and side-effects of statins: a Mendelian randomization study of HMG-CoA reductase inhibition with 55 complex traitsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.